Neutrophils and Polymorphonuclear Myeloid-Derived Suppressor Cells: An Emerging Battleground in Cancer Therapy

Investigators discuss the involvement of polymorphonuclear myeloid-derived suppressor cells in cancer initiation and progression and their potential as therapeutic targets and clinical biomarkers in different cancers.